Robert L Cunningham - Net Worth and Insider Trading

Robert L Cunningham Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert L Cunningham owns 1 companies in total, including AXIM Biotechnologies Inc (AXIM) .

Click here to see the complete history of Robert L Cunningham’s form 4 insider trades.

Insider Ownership Summary of Robert L Cunningham

Ticker Comapny Transaction Date Type of Owner
AXIM AXIM Biotechnologies Inc 2017-05-18 director

Robert L Cunningham Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert L Cunningham Ownership Network

Ownership Network List of Robert L Cunningham

No Data

Ownership Network Relation of Robert L Cunningham

Insider Network Chart

Robert L Cunningham Owned Company Details

What does AXIM Biotechnologies Inc do?

Who are the key executives at AXIM Biotechnologies Inc?

Robert L Cunningham is the director of AXIM Biotechnologies Inc. Other key executives at AXIM Biotechnologies Inc include Chief Operating Officer Kurt Phinney , 10 percent owner Catalina Valencia , and 10 percent owner Glycodots, Llc .

AXIM Biotechnologies Inc (AXIM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AXIM Biotechnologies Inc (AXIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AXIM Biotechnologies Inc (AXIM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AXIM Biotechnologies Inc (AXIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AXIM Biotechnologies Inc Insider Transactions

No Available Data

Robert L Cunningham Mailing Address

Above is the net worth, insider trading, and ownership report for Robert L Cunningham. You might contact Robert L Cunningham via mailing address: 5 Rockerfeller Place, 20th Floor, Suite 83, New York Ny 10111.

Discussions on Robert L Cunningham

No discussions yet.